Pharmacology Flashcards
Mechanisms of resistance
malabsorption, pumping out, inactivation, ineffective, increased production of target molecules, develop alter metabolic pathways
how does resistance arise
temporarily, chomosomally, extrachromosomally (addition of plasmid, multiple gene combination)
how to minimize emergence of resistence
only use when clearly indicated, use as narrow spectrum as possible, use effective dose, consider phenotype/genotype of patient, ensure adequate duration, use older drugs when possible and combination drugs
superinfections
alter the normal flora by removing some, others overgrow in its place
how to distinguish superinfections from side-effects
if they have symptoms immediately after drug infection, it’s a side effect. but if it takes a couple days to set in, it’s a superinfection
three major classes of GI superinfections
candidiasis, staph enterocolitis, and psudomembranous colitis
candidiasis superinfection
fungal overgrowth, most common, continue antibiotic but add antifungal
staphylococcal enterocolitis superinfection
life-threatening superinfection, altered bacterial populations allow the overgrowth of staph, discontinue antibacterial and administer anti-staph penicillin or vancomycin
pseudomembranous colitis superinfection
life-threatening C. diff overgrowth, discontinue antibacterial and administer metronidazole or vancomycin
toxicity
dose-related, tissues that experience higher concentrations are more susceptible
hypersensitivity
drug allergies, immune-mediated, not related to therapeutic dose range
idiosyncratic responses
linked to drugs, but low frequency and not really related to dose, more genetically determined
how to administer the appropriate chemotherapy
based on culture AND susceptibility testing, monitor for therapeutic and toxic effects
purpose of combination therapy
enhanced therapeutic effect (synergism), allow use of lower doses to minimize toxicity, can combine 2 statics and they’ll become cidal, delay resistance, treat mixed infections, and initiate therapy in life-threatening situations before pathogen is known
who is a candidate for chemoprophylaxis
healthy individuals following known exposure, individuals with known dormant pathogen to minimize episodes, post-surgical patients and patients susceptible to endocarditis